This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Hedge Funds' Best Picks Show the Way for 2012

Stocks in this article: BAC C AAPL GOOG BP KFT GE

Health Care

The health care sector was a popular one in the third quarter for hedge fund managers looking for merger-arbitrage opportunities. Takeover targets like Kinetic Concepts, Cephalon and Medco Health Solutions (MHS) were snatched up during the quarter, increasing health care weightings for several hedge fund managers.

The merger activity is one way to explain the strong performance of the health care sector this year. Health care names in the S&P 500 are up 6.1% overall, according to Capital IQ, the second best sector performance this year. The outlook for health care stocks, though, leaves plenty to be desired. After notching only 7% earnings growth in the third quarter, analysts are only calling for 5% earnings growth for the sector in 2012. In addition, health care companies will be in limbo as President Obama's health care reform bill gets challenged in the courts.

If they weren't playing M&A activity in the sector, hedge fund managers were selling for the most part. Pfizer (PFE) was a popular name to sell, with David Tepper's Appaloosa Management and David Einhorn's Greenlight Capital reducing their holdings in the drugmaker. Tepper also sold shares of fellow drug stock Merck (MRK), as well as Medtronic (MDT) and UnitedHealth Group (UNH).

Elsewhere, Steven Cohen's SAC Capital sold out of Dendreon (DNDN), which had been one of the hedge fund's largest holdings before the stock crumbled. Cohen's fund also sold shares of Tenet Healthcare (THC), Express Scripts (ESRX) and Novartis (NVS), among others.

Meanwhile, both Blue Ridge Capital and Omega Advisors cut their holdings in Teva Pharmaceutical (TEVA), although that may be due to the fact that the company's shares fell very sharply in August.

7 of 11

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,908.16 +103.36 0.58%
S&P 500 2,071.83 +1.18 0.06%
NASDAQ 4,773.7480 +8.3680 0.18%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs